Submission Details
| 510(k) Number | K230402 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 15, 2023 |
| Decision Date | April 11, 2023 |
| Days to Decision | 55 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K230402 is an FDA 510(k) clearance for the ENROUTE? Transcarotid Neuroprotection System, a Temporary Carotid Catheter For Embolic Capture (Class II — Special Controls, product code NTE), submitted by Silk Road Medical (Sunnyvale, US). The FDA issued a Cleared decision on April 11, 2023, 55 days after receiving the submission on February 15, 2023. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1250.
| 510(k) Number | K230402 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 15, 2023 |
| Decision Date | April 11, 2023 |
| Days to Decision | 55 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | NTE — Temporary Carotid Catheter For Embolic Capture |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1250 |
| Definition | This Device Is A Single Use Percutaneous Catheter System That Is Introduced Into An Artery Through The Skin Using A Guidewire. The Catheter Has An Embolic Capture Filter Or An Occlusion Balloon At The Distal End. The Filter Or Balloon Can Be Placed Either Distally To The Lesion Or Proximally Depending On The Design Of The Device And Intended Use. The Filter Or Balloon Is Used To Capture Embolic Material In A Manner That May Protect Or Prevent A Stroke Or Other Cerebral Vascular Sequelae. The Embolic Capture Device Is Indicated For Use As A Guidewire And Embolic Protection System To Contain And Remove Embolic Material (thrombus/debris) While Performing Angioplasty And Stenting Procedures I |